Chapter 44 ■ Exchange Transfusions 317

(2) Blood may be anticoagulated with citrate phosphate dextrose (CPD or CPDA1) or heparin

(heparinized blood is not licensed for use in the

United States). Additive anticoagulant solutions

are generally avoided; if there is no other option,

packed red cells stored in additive solutions may

be washed or hard packed prior to reconstitution

for ET (24).

(3) Hematocrit (Hct) may be adjusted within the

range of 45% to 60%, depending on desired end

result.

(4) Blood should be as fresh as possible (<7 days)

(5) Irradiated blood is recommended for all ET to

prevent graft-versus-host disease. There is a significant increase in potassium concentration in

stored irradiated units, so irradiation should be

performed as close to the transfusion as possible

(<24 hours).

(6) Standard blood-bank screening is particularly

important, including sickle cell preparation, HIV,

hepatitis B, and CMV.

(7) Donor blood should be screened for G-6-PD

deficiency and HbS in populations endemic for

these conditions (25).

b. In presence of alloimmunization (e.g., Rh, ABO) special attention to compatibility testing is necessary (9)

(1) If delivery of an infant with severe HDN is

anticipated, O Rh-negative blood cross-matched

against the mother may be prepared before the

baby is born.

(2) Donor blood prepared after the infant’s birth

should be negative for the antigen responsible

for the hemolytic disease and should be crossmatched against the infant.

(3) In ABO HDN, the blood must be type O and

either Rh-negative or Rh-compatible with the

mother and the infant. The blood should be

washed free of plasma or have a low titer of antiA or anti-B antibodies. Type O cells may be used

with AB plasma, but this results in two donor

exposures per ET.

(4) In Rh HDN, the blood should be Rh-negative

and may be O group or the same group as the

infant.

c. In infants with polycythemia, the optimal dilutional

fluid is isotonic saline rather than plasma or albumin (26).

Volume of Donor Blood Required

a. Whenever possible, use no more than the equivalent of one whole unit of blood for each procedure,

to decrease donor exposure.

b. Quantity needed for total procedure = volume for

the actual ET plus volume for tubing dead space

and blood warmer (usually an additional 25 to

30 mL)

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more